Delivery Order SPE2DR25D2012-SPE2DR26F1BMU
- Not listed
- The Defense Logistics Agency awarded a $1,030.56 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of August 19, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.999 billion comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order valued at $1,933.72 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on August 4, 2025, with an ultimate completion date of August 5, 2025. This delivery order was competitively awarded with firm fixed pricing and no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,361.30 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on December 3, 2025, with completion scheduled for December 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, valued at $2,225.66, with an ultimate completion date of October 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under a larger federal contract vehicle. The performance location is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $1,080.34 delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine, with performance at the company's Conshohocken, Pennsylvania location. This non-competitive, firm fixed-price delivery order was issued on December 2, 2025, with an ultimate completion date of December 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfilled this order under its existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,276.75 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on a firm fixed-price basis. The contract, which is non-set-aside and competitively awarded, was issued on November 24, 2025, with an ultimate completion date of November 25, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,954.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of August 21, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $24,284.58 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of ENGERIX-B 20 MCG/ML vaccine syringes. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, was competitively awarded without a set-aside designation. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as one of the...
- The Defense Logistics Agency awarded a delivery order valued at $6,258.56 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes. The contract was competitively awarded without set-aside designation on November 13, 2025, with an ultimate completion date of November 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is priced on a firm fixed-price basis and represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $1,697.25 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on December 3, 2025, with completion scheduled for December 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger relationship with DLA. This delivery...
- SPE2DR25D2012Indefinite Delivery Contract
- SPE2DR25D2012-SPE2DR26F1BMUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,217.67 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on a firm fixed price basis, with delivery expected by December 9, 2025. This non-set-aside award represents a competitive procurement action and leverages AmerisourceBergen's position as a major pharmaceutical distributor supporting federal medical supply needs. The contract was awarded to the vendor's corporate office located in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary operations center. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a child delivery order under this comprehensive pharmaceutical prime vendor agreement, the ENGERIX-B vaccine procurement reflects the company's critical role in supplying vaccines, medications, and medical supplies to support military healthcare systems and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The indefinite delivery vehicle enables AmerisourceBergen to fulfill a wide range of pharmaceutical requirements on a global basis in support of the Department of Defense's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/7/25 |